Calling all women creating technologies, therapeutics and other relevant innovations in cancer research and oncology! Springboard Enterprises and NIH are teaming up for the virtual discussion: "NCI SBIR & STTR: Advancing the Commercialization of New Cancer Innovations."
Approximately 15% of the National Cancer Institute (NCI) SBIR portfolio is made up of women's health technologies. Springboard, NIH and the Women's Health Innovation Coalition are working to increase this number. Join us to learn more about NCI SBIR and STTR awards, resources and associated programs. Our friends at NIH will be presenting an overview of the process and then will be available to answer your questions. We'll also hear from some women entrepreneurs in the oncology space who can share their journey obtaining funding and seeking resources.
Anna Consani, Springboard Enterprises
Christie Canaria, Program Director, NIH
Nancy Kamei, Program Director, NIH
Patti Weber, Program Director, NIH